-
Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial
Janssen, J., Staal, F. H. E., Brouwer, C. L., Langendijk, J. A., de Jong, I. J., van Moorselaar, R. J. A., Schuit, E., Verzijlbergen, J. F., Smeenk, R. J. & Aluwini, S., 1 Dec 2022, In: BMC Cancer. 22, 1, 482.Research output: Contribution to journal › Article › Academic › peer-review
-
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)
van der Werf, I., Wojtuszkiewicz, A., Yao, H., Sciarrillo, R., Meggendorfer, M., Hutter, S., Walter, W., Janssen, J., Kern, W., Haferlach, C., Haferlach, T., Jansen, G., Kaspers, G. J. L., Groen, R., Ossenkoppele, G. & Cloos, J., 1 Sept 2021, In: Leukemia. 35, 9, p. 2735 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds
Janssen, J., Löwenberg, B., Manz, M., Bargetzi, M., Biemond, B., von dem Borne, P., Breems, D., Brouwer, R., Chalandon, Y., Deeren, D., Efthymiou, A., Gjertsen, B. T., Graux, C., Gregor, M., Heim, D., Hess, U., Hoogendoorn, M., Jaspers, A., Jie, A., Jongen-Lavrencic, M., & 26 others , 2 Feb 2021, In: Cancers. 13, 4, p. 1-11 11 p., 672.Research output: Contribution to journal › Article › Academic › peer-review
- All publications